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Diya	Alsafadi,a*	Safaa	Alsalmana	and	Francesca	Paradisib*	
	
Enzymatic	synthesis	of	enantiopure	aromatic	secondary	alcohols	(including	substituted,	hetero-
aromatic	and	bicyclic	structures)	were	carried	out	using	the	halophilic	alcohol	dehydrogenase	ADH2	from	
Haloferax	volcanii	(HvADH2).	This	enzyme	showed	an	unprecedented	
substrate	scope	and	absolute	enatioselectivity.	The	cofactor	NADPH	was	used	catalytically	and	regenerated	
in-situ	 by	 the	 biocatalyst,	 in	 the	 presence	 of	 5%	 ethanol.	 The	 efficiency	 of	HvADH2	 for	 conversion	 of	
aromatic	ketones	was	markedly	influenced	by	the	steric	and	electronic	factors	as	well	as	the	solubility	of	
ketones	in	the	reaction	medium.	Furthermore,	carbonyl	stretching	bands	frequencies	ν ( )	have	been	
measured	for	different	ketones	to	understand	the	effect	of	electron	withdrawing	or	donating	properties	of	
the	 ketones	 substituents	 on	 the	 reaction	 rate	 catalyzed	 by	 HvADH2.	 Good	 correlation	 was	 observed	
between	ν ( )	of	methyl	aryl-ketones	and	the	reaction	rate	catalyzed	by	HvADH2.	The	enzyme	catalyzed	
the	 reductions	 of	 ketone	 substrates	 on	 the	 preparative	 scale,	 demonstrating	 that	HvADH2	would	 be	 a	
valuable	biocatalyst	for	the	preparation	of	chiral	aromatic	alcohols	of	pharmaceutical	interest.	
	
Introduction	
Chirality	is	a	key	factor	in	the	safety	and	efficacy	of	many	drugs	and	thus	the	production	of	enantiopure	
drugs	 has	 become	 increasingly	 important	 in	 the	 pharmaceutical	 industry.1	 Chiral	 aromatic	 secondary	
alcohols	 are	 widely	 used	 in	 synthetic	 organic	 and	 medicinal	 chemistry	 as	 key	 intermediates	 for	 the	
synthesis	 of	 various	 pharmaceutical	 products	 such	 as	 Zetia®	 (Ezetimibe),2	 Prozac®	 (Fluoxetine)3	 and	
Emend® (Aprepitant)	1	(Fig.	1).	
	
	
	
Fig.	1	Examples	of	drugs	derived	from	chiral	aromatic	secondary	alcohols	precursors.	
	
																																																																																																																																																	
A	variety	of	chiral	metal	complexes	have	been	used	as	catalysts	for	enantioselective	synthesis	of	chiral	
aromatic	secondary	alcohols4-5	however,	biocatalytic	transformation	systems	using	cell-free	enzymes6	or	
whole-cell	 microorganisms7	 offers	 advantages	 with	 respect	 to	 high	 catalytic	 efficiency,	 mild	 reaction	
conditions,	outstanding	enantio-,	regio-	and	chemoselectivity	and	being	void	of	toxic	metals.		
		
Alcohol	dehydrogenases	(ADHs,	EC	1.1.1.1)	are	a	class	of	nicotinamide	adenine	dinucleotide	(phosphate)	
[NAD(P)+]-dependent	enzymes	that	catalyse	the	reversible	reduction	of	aldehydes	and	ketones	to	their	
corresponding	alcohols.8	Asymmetric	reduction	of	the	prochiral	ketones	using	ADH	is	an	important	tool	
for	industrial	production	of	enantiopure	alcohols.9-10	Additionally,	ADHs	can	accomplish	dynamic	kinetic	
resolution,11-12	 and	 deracemization	 of	 racemic	 alcohols13-14	 as	 well	 as	 racemization	 of	 enantiopure	
alcohols,15-16	processes	by	which	high	yields	 (theoretically	up	to	100	%)	of	a	single	enantiomer	can	be	
obtained.		
Although	several	ADHs	have	been	identified	from	various	organisms,	their	substrate	scope	tends	to	be	
limited	and	mutagenesis	has	often	been	necessary	to	expand	the	range	of	substrates.17,18	Furthermore,	
cofactor	 regeneration	 must	 be	 taken	 into	 consideration	 to	 minimize	 the	 economic	 impact	 of	 the	
biocatalytic	process.	As	a	consequence,	several	methods	have	been	developed	to	regenerate	the	cofactor	
in	ADH-catalyzed	reactions	such	as	a	coupled	enzyme	system,	or	with	the	use	of	a	second	substrate.6		
Steric	and	electronic	properties	of	substituent	groups	also	play	a	major	role	on	the	biocatalytic	reduction	
of	 aromatic	 ketones.	 ADHs	 from	 Pichia	 glucozyma,19	 Aromatoleum	 aromaticum20	 and	 Lactobacillus	
brevis21	have	been	applied	in	the	asymmetric	reduction	of	acetophenone	derivatives	with	different	size	
and	electronic	properties.	The	formations	of	aromatic	secondary	alcohols	were	explained	by	substrate	
docking	 experiment	 and	 interaction	 energy	 values,20	 σ-Hammett coefficients 19	 and	 IR	 carbonyl	
stretching	bands.21	The	results	have	provided	valuable	insight	into	the	understanding	of	how	ADHs	behave	
with	aromatic	ketones.																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																
There	 are	 a	 limited	 number	 of	 ADHs	 effectively	 useful	 in	 the	 synthesis	 of	 chiral	 aromatic	 secondary	
alcohols	which	have	been	described	in	the	literature.	For	instance,	alcohol	dehydrogenase	from	Ralstonia	
sp.	 (RasADH)	 catalyzed	 the	 reduction	 of	 aromatic	 ketones	 containing	 bulky	 substituents	 with	 high	
enantioselectivity.22	This	type	of	ADHs	has	great	relevance	in	asymmetric	synthesis	because	of	its	broad	
substrate	 scope.	 ADH	 from	 Thermus	 thermophilus	 HB2723	 was	 used	 in	 the	 asymmetric	 reduction	 of	
aromatic	ketones	with	anti-Prelog	selectivity.	Considering	the	value	of	aromatic	chiral	alcohols,	it	will	be	
increasingly	 important	 to	 identify	 more	 ADHs	 that	 can	 be	 employed	 in	 such	 processes	 with	 high	
enantioselectivity.	 Extremophiles	 represent	 a	 promising	 source	 of	 robust	 biocatalysts	 with	 industrial	
applications.	A	number	of	ADHs	 from	extremophiles	have	been	 identified	and	studied	with	respect	 to	
their	ability	to	work	in	harsh	industrial	conditions	such	as	high	temperature24	and	non-aqueous	medium.25-
26	
	As	part	of	our	effort	to	develop	effective	ADHs	for	synthesis	of	industrially	valuable	chiral	alcohols,	we	
developed	 and	 characterized	 four	 novel	 alcohol	 dehydrogenases	 from	 halophilic	 bacteria.27-29	 In	
particular;	 alcohol	 dehydrogenase	 from	 the	 extreme	 halophile	 Haloferax	 volcanii	 (HvADH2)	 showed	
remarkable	activity	and	stability	in	the	presence	of	different	organic	solvents.27	For	easy	recovery	from	
the	reaction	mixture	and	reutilization,	HvADH2	was	also	seccesfully	immobilized	on	solid	support.30	The	
initial	substrate	screening	for	this	enzyme	showed	encouraging	results	towards	benzyl	alcohol27	which	
prompted	further	in	depth	investigation	of	HvADH2	with	industrially	relevant	compounds.		
Herein,	we	 report	 on	 the	 application	 of	HvADH2	 for	 the	 synthesis	 of	 a	 very	 broad	 range	of	 aromatic	
secondary	alcohols.	The	versatility	of	this	enzyme	and	its	adaptability	to	optimized	reaction	conditions	is	
uncommon	 in	 the	 examples	 found	 to	 date	 in	 the	 literature.	 The	 effect	 of	 the	 steric,	 electronic	 and	
solubility	properties	of	the	substrates	on	the	reaction	catalyzed	by	HvADH2	is	also	discussed.	Finally,	IR	
absorption	bands	of	the	carbonyl	group	are	measured	and	correlated	with	the	reaction	rate	catalyzed	by	
HvADH2.			
	
	
	
		
Results	and	discussion	
	
Reduction	of	aromatic	ketone	using	HvADH2	
	
Aromatic	secondary	alcohols	such	as	1-phenylethanol,	1-phenyl-2-propanol	and	4-phenyl-2-butanol	were	
investigated	as	possible	substrates	for	the	alcohol	dehydrogenase	enzyme	from	the	extreme	halophile	
Haloferax	volcanii	(HvADH2)	in	the	oxidation	reaction.			Preliminary	activity	assays	suggested	that	HvADH2	
accepted	aromatic	alcohol	substrates	with	most	marked	activity	observed	against	1-phenyl-2-propanol.	
Therefore,	 1-phenyl-2-propanone	was	 used	 as	 the	model	 substrate	 in	 order	 to	 optimize	 the	 reaction	
conditions	(pH,	temperature,	organic	solvents,	and	co-factor	recycling	system)	in	the	reductive	direction	
with	HvADH2	(Fig	2).				
	
																																								 	
	
Fig.	2	Reduction	of	1-phenyl-2-propanone	using	HvADH2.	
	
Initially,	the	effect	of	pH	on	the	conversion	of	1-phenyl-2-propanone	was	investigated	at	pH	6	and	pH	8,	
where	HvADH2	exhibited	the	highest	activity	for	the	reductive	reaction.27	The	reactions	were	performed	
either	utilizing	a	substrate-coupled	approach	(5%	ethanol)	to	regenerate	the	co-factor	or	with	an	excess	
of	NADPH.	In	both	cases,	the	best	conversion	was	observed	at	pH	8,	in	fact	no	reaction	was	observed	at	
pH	6	in	the	presence	of	5%	ethanol	and	catalytic	amount	of	NADPH	likely	due	to	a	stability	issue	at	the	
lower	pH	over	an	extended	period	of	time.		
	
		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
For	the	cofactor	regeneration,	alcohols	that	had	been	used	as	substrates	in	the	oxidative	reactions	were	
tested	 in	 5%	 concentrations,	 including	 2-propanol,	 1-propanol	 and	 1-butanol,27	however	 only	 ethanol	
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Fig.	 3	 Various	 aromatic	 ketones	 derivatives	 and	 general	 scheme	 of	 their	 reduction	 with	
HvADH2.	
		
performed	well.	 To	determine	 the	optimum	concentration	of	 ethanol	 as	 co-substrate	 in	 the	 reaction,	
different	concentrations	of	ethanol	(5%–20%)	were	trialled	but	already	at	10%	the	conversion	dropped	
to	60%	with	respect	to	the	lower	amount	(results	not	shown).	Likely	acetaldehyde	accumulating	in	the	
media	is	toxic	to	the	enzyme	and	5%	ethanol	was	chosen	for	all	subsequent	reactions.		
To	investigate	the	influence	of	organic	solvents	and	temperature,	the	reduction	of	1-phenyl-2-propanone	
was	carried	out	in	the	presence	of	5%	of	organic	solvents	(dimethyl	sulfoxide,	methanol	and	acetonitrile)	
at	25°C and 50°C. The reactions were monitored by HPLC	analysis	as	described	in	the	experimental	
section.	The	maximum	conversion	of	1-phenyl-2-propanone	(95	%)	was	observed	in	the	presence	of	5%	
of	acetonitrile	at	25°C,	while	the	conversion	recorded	in	DMSO	and	methanol	was	lower	(62	%	and	37	%,	
respectively)	at	the	same	temperature.									
	
Substrate	scope	and	stereoselectivity	of	HvADH2		
	
Several	aromatic	ketones	falling	into	seven	structural	classes	were	selected	based	on	their	potential	for	
the	 production	 of	 industrially	 valuable	 chiral	 aromatic	 alcohols.	Wild-type	HvADH2	was	 used	 for	 the	
enantioselective	reduction	of	each	substrate	class	(Fig.	3).	
The	reactions	were	monitored	by	HPLC	and	the	purity	of	the	product	determined	by	1H-NMR	analysis.	The	
percent	conversion	of	ketones	and	the	e.e.	values	of	the	produced	alcohols	are	reported	in	Table	1.	
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Table	1	Results	from	the	reduction	of	various	aromatic	ketones	
derivatives	using	HvADH2	
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*Reaction	conditions:	4	mM	ketone	(1-29)	 ;	1.5	
mM	 NADP+	 and	 0.3	 mg/mL	 HvADH2	 were	
dissolved	 in	 Tris-HCl	 buffer(100	 mM,	 pH	 8.0)	
supplemented	with	2	M	KCl,		5%	ethanol	and	5%		
acetonitrile,	 reaction	 volume	 1.0	 mL,	
temperature	 25	 °C, reaction time 36 h; 
agitation on an orbital shaker (320 rpm).	
**	%	conv	was	calculated	from	HPLC	analysis.	
	
		
HvADH2	 follows	 rigorously	 Prelog’s rule yielding	 exclusively	 (S)-alcohols	 (100%	 e.e.)	
independently	 of	 the	 substrate	 tested.	Other	 dehydrogenases/reductases	 reported	 in	 the	
literature	 show	 mixed	 selectivity	 depending	 on	 the	 substrate.	 For	 example,	 (S)-1-
phenylethanol	 dehydrogenase	 from	 Aromatoleum	 aromaticum	 showed	 strong	 (S)-	
enantioselectivity	 however,	 a	 racemic	mixture	 of	 1-(4-aminophenyl)ethanol	was	 observed	
when	4′- aminoacetophenone 11	was	tested.20	Additionally,	acetophenone	1	was	reduced	
to	 (R)-1-phenylethanol	 (opposite	 enantiomer)	 with	 95%	 e.e	 using	 benzilketoreductase	
KRED1-Pglu	 isolated	 from	 Pichia	 glucozyma.19	 Alpha-halo	 aryl-ketones	 such	 as	 	 phenacyl	
bromide	17	and	phenacyl	chloride	19	were	reduced	to	their	corresponding	(S)-alcohols	using	
the	short-chain	dehydrogenase	from	Streptomyces	griseus	while,	methyl	aryl-ketones	such	as	
4′-chloroacetophenone 6	and	4-bromoacetophenone	8	were	reduced	to	(R)-alcohols	using	
the	same	biocatalyst.31	Interestingly,	the	stereoselectivity	of	HvADH2	was	maintained	with	all	
aromatic	ketones	(1-27)	tested	in	this	work.			
Clearly,	the	efficiency	of	HvADH2	for	conversion	of	alkyl	aryl-ketones	(set	a)	were	different	
and	markedly	influenced	by	steric	factors	such	as	substrate	size	and	the	type	of	alkyl	chain,	
linear	or	branched.	For	liner	alkyl	chain	ketones	(1-4),	the	smallest	substrate	acetophenone	1	
showed	the	lowest	conversion	(65%).	On	the	other	hand,	HvADH2	effectively	catalyzed	the	
enantioselective	reduction	of	alkyl	aryl-ketones	as	the	alkyl	chain	between	the	carbonyl	group	
and	phenyl	group	became	longer	2	and	3.	Notably,	good	conversion	(76%)	was	observed	with	
the	bulkier	substrate	4.	Thus,	bulky	groups	might	be	better	stabilized	in	the	enzyme	active	
site	in	such	a	way	to	increase	the	catalytic	efficiency	of	the	enzyme.	In	line	with	our	initial	
substrate	scope	investigation,27	no	conversion	was	observed	with	the	substrate	containing	a	
branched	group	5.	It	is	worth	noting	that	the	influence	of	branched	alkyl	chain	on	the	ketones	
reduction	by	ADH	was	not	observed	before	in	the	literatures.		
The	catalytic	activity	of	HvADH2	on	methyl	aryl-ketones	substrates	(set	b)	was	investigated	
using	different	meta-	and	para-	substituted	of	acetophenone	derivatives	(6-16)	and	compared	
to	acetophenone	1	(Table	1).	
HvADH2	effectively	catalyses	the	reduction	of	para-halogenated	acetophenone	derivatives	
(6–8),	with	up	to	80%	conversion.	Para-methylacetophenone	9	gave	satisfactory	conversion	
(55%)	and	the	best	conversion	was	reported	with	para-nitroacetophenone	10	which	yielded	
the	corresponding	(S)-alcohol	almost	quantitatively.	In	contrast,	para-amionoacetophenone	
11	was	not	reduced	by	the	enzyme,	likely	due	to	the	strongly	electron	donating	properties	of	
the	amino	group	as	also	noted	by	Contente	et	al.19	The	difference	on	the	catalytic	activity	of	
HvADH2	toward	acetophenone	derivatives	could	be	explained	by	the	electronic	effect	of	the	
substituents	on	the	reactivity	of	the	carbonyl	group.	A	similar	trend	was	reported	on	an	ADH	
from	L.	Brevis	21	and	a	benzyl	reductase	from	P.	glucozyma.19	However,	for	other	ADHs,	the	
electronic	properties	of	substituted	acetophenones	were	not	as	significant.32		
A	more	comprehensive	study	of	the	influence	of	the	meta-position	on	the	HvADH2	catalytic	
activity	was	carried	out.	In	general,	acetophenone	derivatives	with	halogenated	substituents	
at	meta-position	(12	and	13)	represent	suitable	substrates,	too.	However,	the	halogenated	
meta-substituted	 acetophenones	 gave	 less	 satisfactory	 results	 compared	with	 their	para-
substituted	 counterpart.	 This	 behavior	 was	 not	 observed	 with	 methyl,	 nitro	 and	 amino	
acetophenone	substituents	(14-16),	which	gave	better	conversion	rate	at	meta-position	than	
para-position.	The	influence	of	acetophenone	substituents	on	the	reaction	rate	catalyzed	by	
HvADH2	was	further	investigated	by	monitoring	the	carbonyl	stretching	bands	with	IR	studies	
(see	below).			
		
For	 the	 alpha-halo	 aryl-ketones	 (17-21),	 it	was	 noticeable	 that	 the	 conversion	 rate	 for	α-
fluorinated ketone 18	with	HvADH2	was	better	than	α-chlorinated ketone 19	and	this	one	
was	better	than	α-brominated ketone 17.	These	results	is	consistent	with	both	steric	(atomic	
size	 F <Cl< Br)	 and	 electronic	 (high	 electronegative	 F	 atom	 at	α-position) factors of the 
groups. 	
Interestingly,	 phenacyl	 chloride	 19	 was	 converted	 faster	 than	 	 	 	 	 	 	 	 	 	 	 2-chloro-4′-
fluoroacetophenone 20	 and	 2-chloro-2′,4′-difluoro-acetophenone	21	with	HvADH2.	 This	
indicated	that	the	substituents	on	the	phenyl	ring	of	α-halo-ketone adversely affected the 
rate of enzymatic reaction.	Clearly,	for	substrates	20	and	21	the	steric	effect	is	predominant	
in	 influencing	 the	 reaction	 rate	 rather	 than	 the	 electronic	 effect.	 This	 observation	 is	 also	
confirmed	from	the	conversion	value	of	4-fluoroacetophenone	7	(76%)	which	was	higher	than	
20	and	21	substrates.		
The	choice	of	solvent	played	a	major	role	 in	the	enzymatic	reaction	of	HvADH2	with	beta-
cyano	 aryl-ketones	 (set	 d).	 The	 reduction	 of	 benzoylacetonitrile	 22	 and	 4-
bromobenzoylacetonitrile	 23,	 did	 not	 proceed	 when	 the	 reaction	 was	 performed	 in	 an	
aqueous	 buffer	 containing	 acetonitrile	 (optimum	 co-solvent).	 Therefore,	 acetonitrile	 was	
replaced	by	dimethyl	sulfoxide	in	an	effort	to	increase	the	solubility	of	substrates	containing	
polar	cyano	group	at	α-position.	As	expected,	the	conversion	yields	for	the	substrates	22	and	
23	were	greatly	improved	with	the	addition	of	the	high	polar	solvent	(DMSO)	into	the	reaction	
buffer.	
Enantiopure	1R-[3,5-bis(trifluoromethyl)phenyl]	ethanol	and	its	(S)-enantiomer	are	key	chiral	
intermediates	in	the	synthesis	of	Aprepitant	(a	NK-1	receptor	antagonist).33	The	reduction	of	
24	 had	 been	 previously	 reported	 using	 different	microbial	 strains	 with	 varying	 degree	 of	
success.34	Here,	24e	was	successfully	obtained	with	HvADH2	in	73%	yield	and	100%	e.e.		
2,2,2-trifluoroacetophenone	 25	 was	 tested	 as	 substrate	 for	 HvADH2.	 Surprisingly,	 no	
conversion	was	observed	with	this	substrate.		Acetylpyrazine	compounds	26	and	27	were	only	
minimally	 active	 affording	 low	 conversions	 (<20%).	HvADH2	 like	many	 ADHs35	 fails	 in	 the	
reduction	of	fused	cyclic	ketones	such	as	28	and	29	which	are	particularly	challenging.		
	
IR	carbonyl	stretching	bands	study		
	
To	understand	 the	electronic	effect	of	aromatic	ketones	substituents	on	 the	 reaction	 rate	
catalyzed	by	HvADH2,	the	carbonyl	stretching	bands	for	different	ketones	were	measured	and	
plotted	against	the	%	conversion	of	aromatic	ketones.	The	frequency	values	of	the	carbonyl	
bands	 can	 be	 used	 to	 predict	 the	 carbonyl	 bond	 character	 in	 the	 presence	 of	 electron	
withdrawing	 group	 (EWDG)	 or	 electron	 donating	 group	 (EDG).	 Ketones	 containing	 EWG	
expected	 to	 absorb	 at	 low	 frequency	 values	 (low	 double-bond	 character),	 whereas	 EDG	
suppress	the	delocalization	of	the	aryl-conjugated	carbonyl	and	the	carbonyl	stretching	bands	
observe	at	high	frequency.		
Good	correlation	was	observed	between	the	IR	carbonyl	absorption	bands	of	set	b	ketone	
substrates	6-16	 and	 the	 reaction	 rate	 catalyzed	 by	HvADH2	 (Fig.	 4).	Unexpectedly,	 the	 IR	
absorption	 frequencies	of	 the	carbonyl	group	 increased	with	 the	 reaction	 rate.	Therefore,	
ketones	containing	EWG	absorb	at	higher	frequencies	(higher	double-bond	character),	which	
is	not	in	line	with	the	evidence	of	increased	electrophilicity	of	the	carbonyl	carbon	by	EWG.	A	
similar	trend	has	been	previously	reported	with	the	nucleophilic	acyl	substitutions	of	different	
esters36	 and	 the	 reduction	 of	 ketones	 using	 ADH	 from	 Lactobacillus	 brevis.21	 The	 authors	
attributed	the	high	reactivity	of	esters/ketones	to	the	decrease	of	the	esters/ketones	ground	
		
state	 resonance	stabilization	and	 this	appears	 to	be	due	 to	effect	of	EWG.	 In	contrast,	no	
correlation	was	observed	between	IR	carbonyl	absorption	bands	of	ketone	substrates	from	
sets	(a,	c,	d,	e	and	f)	and	the	reaction	rate	catalyzed	by	HvADH2	(data	not	shown).	This	could	
be	attributed	 to	 the	 influence	of	other	 factors	on	 the	 reaction	 rate	 such	as	 the	 substrate	
solubility	and	substrate	size.		
	
												
	
Fig.	 4	 Correlation	 between	 IR	 carbonyl	 stretching	 bands	 of	 substrates	 6-16	 and	 the	 %	
conversion	 of	 aromatic	 ketones	 in	 the	 reaction	 catalyzed	 by	 HvADH2.	 The	 correlation	
coefficient	r2	=	0.83.	
Conclusion		
	
There	 is	 considerable	 interest	 in	 alcohol	 dehydrogenases	 as	 biocatalysts	 in	 the	
pharmaceutical	industry	for	their	ability	to	produce	valuable	chiral	alcohols.	In	this	work,	we	
have	 shown	 that	 alcohol	 dehydrogenase	 from	 the	 halophilic	 archaeon	Haloferax	 volcanii	
(HvADH2)	effectively	catalyzes	the	enantioselective	reduction	of	a	large	selection	of	aromatic	
ketones	with	high	enantiomeric	purity	to	give	(S)-form	of	aromatic	secondary	alcohols.	The	
co-factor	NADPH	can	be	recycled	by	co-substrate	addition	(5%	ethanol).		
The	 conversion	 of	 aromatic	 ketones	was	 different	 and	 influenced	 by	 (i)	 steric	 factors,	 (ii)	
electronic	 factors,	and	 (iii)	 ketone	solubility.	No	standard	correlation	parameters	could	be	
used	to	explain	the	conversion	of	aromatic	ketones.		For	example,	the	conversion	of	alkyl	aryl-
ketones	(set	a)	were	influenced	predominantly	by	sterics	however,	the	conversion	of	alpha-
halo	aryl-ketones	(set	c),	was	influenced	by	both	steric	and	electronic	factors.	Additionally,	
the	reduction	of	cyano	aryl-ketones	(set	d)	was	greatly	dependant	on	solubility	of	ketones	in	
the	reaction	medium.		
IR	absorption	band	of	the	carbonyl	group	was	then	used	to	investigate	the	effect	of	aromatic	
ketones	substituents	on	the	reaction	rate	catalyzed	by	HvADH2	and	 it	was	concluded	that	
electron	withdrawing	groups	have	positive	effect	on	ketones	 reactivity	by	destabilizing	 its	
ground-state	resonance.		
The	results	confirmed	the	suitability	of	HvADH2	as	a	valuable	biocatalyst	for	the	preparation	
of	chiral	secondary	alcohols	of	pharmaceutical	interest.		
	
Experimental		
Chemicals		
	
All	reagents	and	solvents,	unless	stated	otherwise,	were	purchased	as	analytical	grade.	
Substrates,	 reagents,	 and	 cofactors	 were	 purchased	 either	 from	 Sigma	 Aldrich	 or	 Apollo	
Scientific	 Ltd,	 UK.	 Racemic	 alcohols	 were	 prepared	 from	 the	 corresponding	 ketones	 as	
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follows.	 Ketones	 1-29	 (15	 mmol)	 were	 dissolved	 in	 methanol	 (2	 mL)	 at	 0˚C. Sodium	
borohydride	(0.5	equiv)	was	added	and	the	reaction	mixture	was	incubated	with	shaking	for	
1	h	at	0°C. 1M HCl was added dropwise  to maintain the reaction temperature below	5	
˚C. Methanol	was	evaporated	using	a	gentle	 stream	of	nitrogen.	Then,	water	 (5	mL)	was	
added	and	the	solution	was	extracted	with	ethyl	acetate	(3	x	5	mL).	The	organic	layers	were	
combined	and	dried	over	Na2SO4.	The	solvent	was	evaporated	and	the	residue	was	subjected	
to	chromatography	separation.		
	
Protein	expression	and	purification	
	
HvADH2 was	 homologously	 overexpressed,	 using	 the	 vector	 pTA963	 and	 host	 strain	Hfx.	
volcanii.	The	vector	features	an	inducible	L-tryptophan	promoter	and	has	a	hexahistidine-tag,	
which	allowed	for	easy	purification	by	immobilized	metal	affinity	chromatography	(IMAC).27		
Haloferax	 volcanii	 was	 grown	 overnight	 at	 45	 ◦C	 on	 270	 mL	 Hv-YPC	 medium.	 Protein	
overexpression	was	induced	by	the	addition	of	30	mL	(50	mM)	L-tryptophan	to	final	volume	
300	mL	of	growth	medium.	After	24	h	the	culture	was	harvested	by	centrifugation	at	4,000	
rpm	for	10	min.	Cell	pellets	were	resuspended	in	lysis	buffer	(50	mM	Tris-HCl,	pH	8,	containing	
KCl	(3	M)	and	disodium	EDTA	(2	mM)).	Cells	were	lysed	by	sonication	until	the	suspension	was	
no	longer	turbid.	The	cell	lysate	was	clarified	by	centrifugation	at	18,000	rpm,	4	◦	C	for	30	min.	
After	centrifugation,	the	supernatant	was	filtered	through	a	0.45	µm membrane and loaded 
on to a chromatography column filled with Ni Sepharose 6 Fast Flow resin.	The	His-
tagged	protein	eluted	when	10	%	(5	mM	disodium	EDTA)	to	30	%	(15	mM	disodium	EDTA)	of	
elution	buffer	was	applied.	The	purity	of	protein	samples	was	assessed	by	sodium	dodecyl	
sulfate	polyacrylamide	gel	electrophoresis	(SDS-PAGE).	
	
Analytical	methods	
	
The	 activity	 of	HvADH2	was	 analyzed	 spectrophotometrically	 by	 detecting	 the	 increase	 in	
absorbance	at	340	nm,	which	corresponds	to	the	formation	of	the	cofactor	NADPH,	using	a	
Biochrom	 Libra	 S50	 UV–Visible spectrophotometer.	 Enantiomeric	 excess	 (e.e.)	 and	
conversion	rate	were	determined	by	normal	phase	high	performance	liquid	chromatography	
(HPLC)	using	an	Agilent	1100	series	HPLC	with	chiral	columns	as	the	following:	Chiralcel	OJ-H	
(250x4.6	mm	and	5µm silica gel), Dr. MAISCH Germany, Reprosil Chiral-BM (250x4.6 
mm and 5µm silica gel) alternative to	OB-H	column	and	Phenomenex	USA,	Lux	cellulose-1	
column	 (250x4.6	mm	and	10µm silica gel) alternative to	OD-H	column.	 1H-NMR	spectra	
were	recorded	with	Bruker	500	MHz−Avance III spectrometer. Chemical shifts (δ) are 
expressed in ppm and coupling constants (J)	are	expressed	in	Hz.	Optical	rotation	values	
([α]20D)	were	measured	on	a	PolAAr	21	polarimeter	at	589	nm	in	a	1	dm	cuvette	at	20	°C. 
Fourier	transform	infrared	(FT-IR)	spectra	for	ketones	were	obtained	in	the	range	400	cm-1	to	
4,000	cm-1	using	IR-Prestige-21	Shimadzu	FT-IR	spectrophotometer.		
	
General	procedure	for	reduction	of	ketones	and	sample	pre-treatment	for	HPLC	analysis	
Ketone	 reduction	 was	 carried	 out	 in	 5	 mL	 screw-capped	 test	 tubes	 under	 the	 following	
conditions:	 4	mM	ketone	 (1-29),	 1.5	mM	NADP+	and	0.3	mg/mL	HvADH2	were	dissolved/	
suspended	in	1	mL	of	100	mM	Tris-HCl	pH	8.0	supplemented	with	2	M	KCl,		5%	ethanol	and	
5%	 	acetonitrile.	For	benzoylacetonitrile	22	 and	4-bromobenzoylacetonitrile	23,	5%	DMSO	
		
was	 used	 as	 co-solvent	 instead	 of	 acetonitrile.	 All	 reactions	were	 incubated	 in	 an	 orbital	
shaker	at	25°C, 320 rpm for 96 h.	
The	reaction	mixtures	were	extracted	with	ethyl	acetate	(3×500µL). The organic layer was 
dried over anhydrous sodium sulfate and transferred to a HPLC vial.	The	ethyl	acetate	
was	evaporated	using	a	gentle	stream	of	nitrogen	and	the	residue	was	re-dissolved	in	1	mL	
hexane.	 The	 solubility	 of	 4-aminoacetophenone	 11,	 3-aminoacetophenone	 16	 and	 2-
acetylpyrazine	26	in	hexane	was	low	and	isopropanol	was	used	in	this	case.		
	
General	procedure	for	reduction	of	ketones	on	quantitative	scale	
	
The	biotransformation	on	the	preparative	scale	was	set	up	on	a	20	mM	for	each	substrate.	
The	reactions	were	performed	as	described	before	on	the	analytical	scale.	The	alcohols	from	
set	a,	b	and	c	were	prepared	with	HvADH2	in	moderate	to	very	good	yields	(30–90%). The 
isolated yields for alcohols from set f and d were low (20	%).	To	fully	characterize	the	
alcohols	the	products	residue	were	purified	by	preparative	TLC	using	n-hexane/ethyl	acetate	
(3:1,	v/v)	as	an	eluent	Full	spectra	and	analysis	are	reported	in	the	ESI.		
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